US › Healthcare

Treace Medical Concepts Inc (TMCI)

US · Healthcare · Medical Devices

$3.87-6.07%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$45.4M

Revenue YoY

-4.2%

Net profit

$-15.9M

EPS

$-0.24

EPS estimate

$-0.30

Net margin

-35.0%

EPS came in at -0.24 against a street estimate of -0.30 — a beat of 20.0%.

Key statistics

Market cap

$251.7M

Forward P/E

0.0

P/B

4.33

Book value

$1.04

EPS (TTM)

$-0.90

52-week high

$7.08

52-week low

$1.17

50-day MA

$4.48

200-day MA

$3.15

Beta

1.49

Analyst view

Analysts rate Treace Medical Concepts Inc a hold (1 buy, 3 hold, 1 sell out of 5) with an average price target of $5.50.

Shareholding

Insiders

25.24%

Institutions

49.32%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	9.79%
Bank of America Corp	5.08%
Gagnon Securities LLC	4.66%
Vanguard Capital Management, LLC	3.12%
Gagnon Advisors, LLC	2.36%
AQR Capital Management LLC	2.30%
BlackRock Inc	2.12%
Marshall Wace Asset Management Ltd	2.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Treace Medical Concepts Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.